Skip to main content
Premium Trial:

Request an Annual Quote

NYGC: Thomas Lehner

Thomas Lehner has been appointed as scientific director of neuropsychiatric disease genomics at the New York Genome Center. He will join the center on Jan. 6, 2020. Lehner comes to the NYGC from the National Institute of Mental Health, where he was most recently director of the Office of Genomics Research Coordination and senior genomics advisor of the intramural research program. Prior to joining NIMH in 2004, he held academic research positions at Columbia University and at Rockefeller University. He also worked at Millennium Pharmaceuticals and for the New York State government. Lehner holds a PhD in human biology and genetics from the University of Vienna and a master's degree of public health from Columbia University.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.